PPARD and colitis: Pro-tumorigenic activities of PPARβ/δ have been demonstrated in many colon cancer mouse models, including ApcMin/+ mice [46], azoxymethane-induced colon tumors [47], colitis-associated colon cancer [48], high-fat diet or PPARβ/δ agonist-treated mice [49].